Cargando…

Glioma immunoediting, a driver of tumor evolution, and the next battle for immunotherapy

Detalles Bibliográficos
Autores principales:	Sonabend, Adam M., Stupp, Roger, Lee-Chang, Catalina, Okada, Hideho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7800771/ https://www.ncbi.nlm.nih.gov/pubmed/33456708 http://dx.doi.org/10.18632/oncotarget.27865

Ejemplares similares

Delivering albumin-bound paclitaxel across the blood-brain barrier for gliomas
por: Gould, Andrew, et al.
Publicado: (2021)

Exosomes in cancer immunoediting and immunotherapy
por: Zhao, Yarong, et al.
Publicado: (2022)

Cancer Immunoediting and beyond in 2021
por: Borroni, Elena Monica, et al.
Publicado: (2021)

Next Steps for Immunotherapy in Glioblastoma
por: Cao, Toni Q., et al.
Publicado: (2022)

Novel strategies for cancer immunotherapy: counter-immunoediting therapy
por: Liu, Shaochuan, et al.
Publicado: (2023)

Targeting immune checkpoints potentiates immunoediting and changes the dynamics of tumor evolution
por: Efremova, Mirjana, et al.
Publicado: (2018)

MicroRNAs at the Crossroad between Immunoediting and Oncogenic Drivers in Hepatocellular Carcinoma
por: Gramantieri, Laura, et al.
Publicado: (2022)

Immune-Checkpoint Blockade and Active Immunotherapy for Glioma
por: Ahn, Brian J., et al.
Publicado: (2013)

Melanoma immunoediting by NK cells
por: Balsamo, Mirna, et al.
Publicado: (2012)

Immunotherapy Approaches in Isocitrate-Dehydrogenase-Mutant Low-Grade Glioma
por: Gallus, Marco, et al.
Publicado: (2023)

The shared frameshift mutation landscape of microsatellite-unstable cancers suggests immunoediting during tumor evolution
por: Ballhausen, Alexej, et al.
Publicado: (2020)

Immunoediting and Antigen Loss: Overcoming the Achilles Heel of Immunotherapy with Antigen Non-Specific Therapies
por: Monjazeb, Arta Monir, et al.
Publicado: (2013)

The Janus Face of Death Receptor Signaling during Tumor Immunoediting
por: O’ Reilly, Eimear, et al.
Publicado: (2016)

Tumor-Derived Extracellular Vesicles in Cancer Immunoediting and Their Potential as Oncoimmunotherapeutics
por: Najaflou, Meysam, et al.
Publicado: (2022)

Genetically Engineered T-Cells for Malignant Glioma: Overcoming the Barriers to Effective Immunotherapy
por: Chuntova, Pavlina, et al.
Publicado: (2019)

Battling burnout
por: The Lancet Rheumatology
Publicado: (2022)

Lessons from Cancer Immunoediting in Cutaneous Melanoma
por: Aris, Mariana, et al.
Publicado: (2012)

Cancer immunoediting: A game theoretical approach
por: Tavakoli, Fatemeh, et al.
Publicado: (2021)

Cancer stem cell immunoediting by IFNγ
por: Galassi, Claudia, et al.
Publicado: (2023)

Battling quiescence for tumor eradication: too good to be true?
por: McCarty, Nami
Publicado: (2018)

To exploit the 5 ‘R’ of radiobiology and unleash the 3 ‘E’ of immunoediting: ‘RE’-inventing the radiotherapy-immunotherapy combination
por: Daguenet, Elisabeth, et al.
Publicado: (2020)

DNA barcoding reveals ongoing immunoediting of clonal cancer populations during metastatic progression and immunotherapy response
por: Baldwin, Louise A., et al.
Publicado: (2022)

Immune checkpoint blockade in glioblastoma: from tumor heterogeneity to personalized treatment
por: Arrieta, Víctor A., et al.
Publicado: (2023)

Immunoediting: evidence of the multifaceted role of the immune system in self-metastatic tumor growth
por: Enderling, Heiko, et al.
Publicado: (2012)

Battle Creek Sanitarium
Publicado: (1916)

Expression of tumour-specific antigens underlies cancer immunoediting
por: DuPage, Michel, et al.
Publicado: (2012)

Have Cells Harboring the HIV Reservoir Been Immunoedited?
por: Huang, Szu-Han, et al.
Publicado: (2019)

Immunosurveillance and Immunoediting of Lung Cancer: Current Perspectives and Challenges
por: Kunimasa, Kei, et al.
Publicado: (2020)

Neoantigen quality predicts immunoediting in survivors of pancreatic cancer
por: Łuksza, Marta, et al.
Publicado: (2022)

Cancer immunoediting hypothesis: history, clinical implications and controversies
por: Lasek, Witold
Publicado: (2022)

Tumor-Infiltrating Dendritic Cells: Decisive Roles in Cancer Immunosurveillance, Immunoediting, and Tumor T Cell Tolerance
por: Katopodi, Theodora, et al.
Publicado: (2022)

Modeling cancer immunoediting in tumor microenvironment with system characterization through the ising-model Hamiltonian
por: Rojas-Domínguez, Alfonso, et al.
Publicado: (2022)

VIRAL HEPATITIS, THE BATTLE CONTINUES
por: Al-Freihi, Hussein M.
Publicado: (1997)

The Battle against Cardiogenic Shock
por: Rahamim, Eldad, et al.
Publicado: (2022)

Osteoporosis treatment: the battle to be won
por: Borges, Joao Lindolfo C
Publicado: (2020)

The Eclectic Nature of Glioma-Infiltrating Macrophages and Microglia
por: Arrieta, Víctor A., et al.
Publicado: (2021)

Tumor-reactive immune cells protect against metastatic tumor and induce immunoediting of indolent but not quiescent tumor cells
por: Payne, Kyle K., et al.
Publicado: (2016)

Cancer immunoediting by the innate immune system in the absence of adaptive immunity
por: O’Sullivan, Timothy, et al.
Publicado: (2012)

A proposed role for neutrophil extracellular traps in cancer immunoediting
por: Berger-Achituv, Sivan, et al.
Publicado: (2013)

HTLV-1 as a Model for Virus and Host Coordinated Immunoediting
por: Mota, Talia M., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_nvfrho6a278km2htj4ltbe8us6